Arbutus Biopharma Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Warminster, PA
ABUS chart
What traders are saying about $ABUS
Latest postsArbutus Biopharma Corp news
- Arbutus Biopharma Corporation Estimates – NASDAQ:ABUS
TradingView ·
- Arbutus Biopharma Corporation (ABUS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Form 8K Arbutus Biopharma Corp For: 22 October By Investing.com
Investing.com Nigeria ·
- Why Is Arbutus Biopharma Stock Trading Higher Today? - Arbutus Biopharma (NASDAQ:ABUS)
Benzinga ·
- Why is Arbutus Biopharma stock climbing today? By Investing.com
Investing.com Nigeria ·
- FDA lifts clinical hold on Arbutus Biopharma AB-101 IND application
TipRanks ·
- FDA Lifts Clinical Hold on Arbutus Biopharma's AB-101, Ticker ABUS Advances Clinical Development
GuruFocus ·
- FDA lifts clinical hold on Arbutus Biopharma's AB-101 drug candidate
StreetInsider ·
- Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
Yahoo Finance ·
- The FDA lifted a hold on Arbutus' experimental oral hepatitis B drug.
Stock Titan ·
- Is Arbutus Biopharma (NASDAQ:ABUS) Penny Stock Being Overlooked After a Moderna Settlement Payment and a $230 Million Tender Offer?
kalkine.ca ·
- Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
Yahoo Finance ·
Arbutus Biopharma Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.1M | $6.2M | $18.1M | $39.0M |
| Net income | -$33.5M | -$69.9M | -$72.8M | -$69.5M |
| Diluted EPS | $-0.17 | $-0.38 | $-0.44 | $-0.46 |
| Total assets (year end) | $94.6M | $131.7M | $144.4M | $195.4M |
| Cash and equivalents (year end) | $18.0M | $36.3M | $26.3M | $30.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arbutus Biopharma Corp
- Ticker
- ABUS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warminster, PA
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1447028
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
Frequently asked questions
What exchange is Arbutus Biopharma Corp listed on?
Arbutus Biopharma Corp trades on the Nasdaq under the ticker symbol ABUS.
What industry is Arbutus Biopharma Corp in?
Arbutus Biopharma Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arbutus Biopharma Corp headquartered?
Arbutus Biopharma Corp's business address on file with the SEC is in Warminster, PA.
When does Arbutus Biopharma Corp's fiscal year end?
Arbutus Biopharma Corp's fiscal year ends on December 31.
How much revenue did Arbutus Biopharma Corp report?
Arbutus Biopharma Corp reported $14.1M in revenue for calendar year 2025, according to its SEC filings.